Είστε εδώ

Δημοσιεύσεις Μελών ΕΟΠΕ

Στην ενότητα αυτή, μπορείτε να βρείτε λίστα με δημοσιεύσεις των μελών της Ε.Ο.Π.Ε. σε έγκριτα επιστημονικά περιοδικά.

Τίτλος Συγγραφείς Ημερομηνίααύξουσα ταξινόμηση Πηγή
Improved outcome of high-risk early HER2-positive breast cancer with high CXCL13/CXCR5 mRNA expression. E.Razis, K.T.Kalogeras, V.Kotoula, A.Eleftheraki, N.Nikitas, R.Kronenwett, E.Timotheadou, C.Christodoulou, D.Pectasides, H.Gogas, R.Wirtz, T.Makatsoris, D.Bafaloukos, G.Aravantinos, D.Televantou, N.Pavlidis, G.Fountzilas. 09/2012 Clinical Breast Cancer, 2012; 12[3]: 183-193
Jaw Osteonecrosis Associated with Medication: Report of two cases addresing unresolved clinical research questions. O.Nikolatou-Galitis, D.Bafaloukos, E.Razis, E.Papadopoulou, H.Linardou, I.Grossi, E.Vardas, A,C,Migliorati. 09/2012 MOJ;2012:1;45-51.
 
BRCAness: Finding the Achilles Heel in Ovarian Cancer G.Rigakos, E.Razis. 09/2012 The Oncologist 2012;17:1-7
Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer. Voutsina A, Tzardi M, Kalikaki A, Zafeiriou Z, Papadimitraki E, Papadakis M, Mavroudis D, Georgoulias V. 08/2012 Mod Pathol. 2012 Aug 31. doi: 10.1038/modpathol.2012.150. [Epub ahead of print]
BRCAness: Finding the Achilles Heel in Ovarian Cancer G.Rigakos, E.Razis 06/2012 The Oncologist 2012;17:1-7
A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer. Karachaliou N, Ziras N, Syrigos K, Tryfonidis K, Papadimitraki E, Kontopodis E, Bozionelou V, Kalykaki A, Georgoulias V, Mavroudis D. 06/2012 Cancer Chemotherapy and Pharmacology
Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer. Androulakis N, Agelaki S, Perraki M, Apostolaki S, Bozionelou V, Pallis A, Kalbakis K, Xyrafas A, Mavroudis D, Georgoulias V. 06/2012 British Journal of Cancer. 106(12):1917-25. doi: 10.1038/bjc.2012.202.
Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study. Kentepozidis N, Soultati A, Giassas S, Vardakis N, Kalykaki A, Kotsakis A, Papadimitraki E, Pantazopoulos N, Bozionellou V, Georgoulias V. 06/2012 Cancer Chemotherapy and Pharmacology
The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer. Gioulbasanis I, Pallis A, Vlachostergios PJ, Xyrafas A, Giannousi Z, Perdikouri IE, Makridou M, Kakalou D, Georgoulias V. 04/2012 Lung Cancer
Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: A phase II multicenter study of the Hellenic Oncology Research Group. Mountzios G, Emmanouilidis C, Vardakis N, Kontopodis E, Hatzidaki D, Popis E, Karachaliou N, Kotsakis A, Agelidou M, Georgoulias V 03/2012 Lung Cancer. 2012 Mar 12. [Epub ahead of print]

Σελίδες